Edwards Lifesciences Corporation · NYSE:EW
Zovighian Bernard J sold 36,351 Edwards Lifesciences Corporation shares (Form 4)
Traded May 11 to May 12, 2026 · Filed May 12, 2026
From May 11 to May 12, 2026, Zovighian Bernard J (Director, CEO) sold 36,351 Edwards Lifesciences Corporation shares at an average US$77.93 for US$2.83M under a trading plan, leaving 12,040 shares. Filed May 12, 2026 (Form 4).
- Sold
- 36,351 shares
- Price
- US$77.93 average (US$77.92 to US$78.40)
- Value
- US$2.83M
- Holding after
- 12,040 shares (held indirectly)
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 11, 2026 | Common Stock | Option exercise | 47,207 | 157,492 | Direct | |
| May 11, 2026 | Common Stock | Shares withheld for tax | 26,198 | US$79.96 | 125,805 | Direct |
| May 12, 2026 | Common Stock | Gift | 26,640 | 48,391 | Indirect | |
| May 12, 2026 | Common Stock | Sale | 845 | US$78.40 | 47,546 | Indirect |
| May 12, 2026 | Common Stock | Sale | 35,506 | US$77.92 | 12,040 | Indirect |
Source
Related
- Edwards Lifesciences Corporation
- Zovighian Bernard J
- Edwards Lifesciences Corporation shareholders
- Form 4 · Zovighian Bernard J · Jul 27, 2026
- Form 4 · Zovighian Bernard J · Jun 17, 2026
- Form 4 · Zovighian Bernard J · May 11, 2026
- Form 4 · Zovighian Bernard J · May 5, 2026
- Form 4 · Lippis Daniel J. · Oct 8, 2026
- Form 4 · Markowitz Wayne · Sep 14, 2026
- Form 4 · Dahl Andrew M. · Sep 14, 2026
- Form 4 · Lippis Daniel J. · Sep 11, 2026
- Form 4 · Chopra Daveen · Sep 11, 2026